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Abstract: Current knowledge confi rms the existence of interstitial cells of Cajal (ICCs) and telocytes in 
the urinary system (kidneys, ureter and urinary bladder). Th erefore, summarizing of available data can 
be helpful in understanding of pathophysiology of urological disorders. Telocytes (TCs) are a newly dis-
covered type of cell with numerous functions, described in vertebrates (fi sh, reptiles, birds, mammals, in-
cluding human). Despite unique characteristics, they have own diff erences in morphology and properties 
in urinary bladder and other organs of the urinary system. Th is review summarizes particular features 
of ICCs and TCs in the urinary system, emphasizing their involvement in physiological and pathophysi-
ological processes of the urinary bladder.
Key words: telocytes; interstitial Cajal-like cells (ICLC); interstitial cells of Cajal (ICC); CD34: detrusor; 
urinary tract, ureter, urinary bladder, an overactive urinary bladder; PDGFRα.
Interstitial cells of Cajal (ICCs) were fi rst described by Ramon y Cajal over 100 years 
ago as a  specifi c gut neuron. Formerly called “interstitial neurons”, these cells were 
re-discovered approximately 20 years ago and have been successfully identifi ed using 
contemporary methods, including electron microscopy and immunohistochemistry 
[1–3]. ICCs are found along the entire gastrointestinal tract and are localized mainly 
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in the smooth muscle layers of the gut. ICCs are known to play an important role 
in the control of gastrointestinal tract motility by providing electrical impulses for 
slow wave generation and regulating smooth muscle activity and neurotransmission 
[4–7]. A characteristic feature of ICCs is the expression of transmembrane tyrosine 
kinase receptor proteins, including the c-Kit receptor (CD117), which enables the 
identifi cation of ICCs using immunohistochemical and molecular methods [8]. 
Disturbances in gastrointestinal motility aft er the loss of or damage to ICCs have 
been widely reported in several clinical states, including gastroparesis, constipation, 
achalasia, Chagas disease, Hirschprung’s disease, congenital hypertrophic pyloric 
stenosis, intestinal pseudo-obstructions, and diverticular disease of the colon [6, 7].
Multiple research teams have investigated cells located in various tissues outside 
of the gut, including the pancreas, ureter, urethra, bladder, blood vessels, male and 
female reproductive organs, mammary glands, placenta, heart, and lungs, that are 
similar to ICCs [9–11]. Th ese cells are known as interstitial Cajal-like cells (ICLCs), 
a  term that was proposed by Popescu and Faussone-Pellegrini in 2010 to be replaced 
by “telocytes” [10, 11]. 
We want to summarize current knowledge and emphasis that at least fi ve classes 
of cells in the urinary system has been discussed in literature: interstitial cells (IC), 
interstitial cells of Cajal (ICCs), interstitial cell-like Cajal (ICLCs), telocytes (TCs) 
and fi broblast-like cells (FLC). Several subgroups of IC are located within the bladder 
wall and make structural interactions with nerves and smooth muscle [12], while 
Vannucchi et al. noted that term “IC” is quite vague [13]. ICCs were fi rstly discovered 
in gastrointestinal tract but later were detected in tissues of the urogenital tract [14]. 
Rasmussen et al. reported that two main types of interstitial cells were identifi ed by 
transmission electron microscopy (TEM) in the human detrusor: ICLCs and FLC 
[15]. Interstitial cells of Cajal-like cells in the human urinary bladder do not appear to 
be directly involved in pacemaker activity. Th ey might act as neuromodulators (in the 
lamina propria) [15]. Nowadays, TCs is the matter of considerable scientifi c interest, 
which required more investigations and proved results.
Interstitial cells of Cajal in the urinary system
In recent years, novel type of cells was found in diff erent organs of the urinary 
system, named as interstitial cells of Cajal. Most of the scientists noted these cells 
act as pacemakers, driving peristaltic activity throughout the gut and have a  key 
role acting as intermediaries in the transmission of signals from nerves to smooth 
muscle [16, 17]. 
In 2000 Sergeant et al. described specialized pacemaking cells (ICCs) in the rabbit 
urethra that may be responsible for initiating the slow waves recorded from smooth 
muscle cells in the intact syncytium. Th ey were cells, which were morphologically 
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distinct from normal smooth muscle cells and have varying numbers of branches [18]. 
In two years, McCloskey et al., using anti-c-kit labeling, showed that ICCs are located on 
the boundary of smooth muscle bundles in the guinea pig bladder [19]. Solari et al. in 
2003 fi rstly proposed that the altered density of c-Kit positive cells in ureteropelvic 
junction (UPJ) obstruction may have a role in the failure of transmission of peristaltic 
waves across the UPJ [20]. Huizinga et al. in 2005 in their paper emphasized on the 
criteria that should be used to identify ICCs outside the musculature of the gut [9].
ICCs were detected in in the lamina propria region (ICC-LP) between the 
urothelial layer and the muscularis of the detrusor, while Sui et al. depicted ICCs in 
the sub-urothelial layer [21]. Th ey were located close to nerves and make contacts 
between ICC-LP and nerves [16, 22]. Although, ICCs in the detrusor muscularis 
of the guinea-pig and mouse are distinctively diff erent from the ICC-LP, both in 
distribution and morphology [16, 17, 23]. Piaseczna-Piotrowska et al. demonstrated 
the distribution of ICCs is diff erent in the trigonum and the corpus of the urinary 
bladder [24]. 
ICCs have potential plasticity and have own spontaneous activity. They are 
responsible for Ca2+ waves generation and neuromuscular transmission. ICCs are also 
involved in the conjugation, propagation and modulation of peristaltic waves in the 
upper urinary tract. Bladder ICCs acting as a  conduit for the relay of information 
from the urothelium to the underlying detrusor. Th ese pacemakers play a signifi cant 
role in bladder dysfunction [23, 25–28]. 
We cannot omit in the contest of article’s subject the polemic has occurred 
in the scientifi c world during a  year. Senol et al. demonstrated that in cases of the 
ureteropelvic junction (UPJ) obstruction the numbers of interstitial Cajal cells were 
decreased, being either absent or signifi cantly reduced [29]. In the response Cisek 
wrote in his commentary to the article, that “Th e association of change in ICC density 
and obstruction is correlative, and the pathophysiologic inferences remain speculative 
(cum hoc ergo propter hoc fallacy, or correlation is not causation)” [30].
Era of Telocytes in the urinary system
In the same time, in 2005 L.M. Popescu’s group from Bucharest, Romania, described 
a  new type of cell that resides in the stroma of several organs, which became known 
as interstitial Cajal-like cells. Th ese cells have been shown to diff er from fi broblasts 
and mesenchymal stem cells. A few years later, in 2008, M.S. Faussone-Pellegrini 
and her team from Florence, Italy, described ICLCs in the muscle coat of the human 
gut and noticed they consistently diff ered from the ICCs in both ultrastructure and 
immunophenotype. Finally, in 2010, aft er confi rming the presence of this particular 
cell type in the stroma of many organs and characterized it by immunohistochemistry 
and electron microscopy, the two groups agreed they were describing a ‘novel’ cell type 
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and that the name ICLCs should be changed to a  more appropriate one — Telocytes 
(TCs). Transmission electron microscopy is considered the most accurate method for 
identifying TCs, oft en combined with a double immunolabeling [10, 11, 31–33].
TCs have been found in a  large variety of organs: heart (endo-, myo-, epi- and 
pericardium, myocardial sleeves, heart valves), digestive tract and annex glands 
(esophagus, stomach, duodenum, jejunum, liver, gallbladder, salivary gland, exocrine 
pancreas), respiratory system (trachea and lungs), urinary system (kidney, renal pelvis, 
ureters, bladder, urethra), female reproductive system (uterus, Fallopian tube, placenta, 
mammary gland), vasculature (blood vessels, thoracic duct), serous membranes 
(mesentery and pleura), and other organs (skeletal muscle, meninges and choroid 
plexus, neuromuscular spindles, fascia lata, skin, eye, prostate, bone marrow). Th ey 
have unique morphology, own immunohistochemical and gene profi les, secretomes, 
electrophysiological properties, and make homo- and heterocellular contacts, involved 
in a variety of physiological and pathological processes [10, 34, 35].
Telocytes have very long cellular extensions — telopodes (Tps), which are probably 
the longest cellular prolongations in the human body. Tps are made by an alternation 
of dilated portions, named podoms (250–300 nm), containing mitochondria and 
endoplasmic reticulum and podomers (~80 nm) with thin segments. Likewise, 
they  make homo- and heterocellular junctions and form three-dimensional net-
works   [ 34–36]. Despite the fact that have not yet been found a  specifi c marker for 
TCs, usually for primary identifi cation scientists use CD34 [33]. Th ese cells are usually 
located in the vicinity of smooth muscle cells, nerves, immunocytes (macrophages, 
mast cells and lymphocytes), stem cells, melanocytes [37], erythrocytes [38] and with 
Schwann cells in the heart [39]. Th ey might be involved in the signaling processes, 
motility, reparation, immunological responses and pathophysiological background of 
diseases [10, 31, 32, 35]. 
Telocytes are present in the upper lamina propria of the human renal pelvis, 
ureter and urethra, as well as in kidney (in sub-capsular space) and urinary bladder 
[40, 41]. In ureter and urinary bladder, they mainly exist in between smooth muscle 
bundles [40]. Telocytes have also been identifi ed around renal tubules and vessels 
in the kidney cortex interstitium, with shed vesicles identified in close vicinity 
of TCs  [41,  42]. In the upper lamina propria of renal pelvis, ureter and urethra 
these cells have similar ultrastructural features which were diff erent from those of 
bladder TCs:
1) thinner and longer cytoplasmic prolongations; 
2) presence of dense core granules and microtubules;
3) no peripheral actin fi laments.
Both steroid hormone receptors (estrogen and progesterone) are expressed 
in male and female the upper lamina propria TCs [43–45]. Estrogen receptor 
immunoreactivity has been reported in human urethra, but not in human bladder, 
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while progesterone receptor immunoreactivity has been described in human bladder 
mucosa. Th e expression of one or both of these receptors indicates that the function 
of ureteropelvic junction (ULP) TCs is at least partially influenced by steroid 
hormones [40, 45, 46].
Telocytes in diff erent parts of urinary tract (renal pelvis, ureter, bladder and 
urethra) demonstrated range of immunoreactivity to caveolin-1, estrogen and 
progesterone receptors, which indirectly indicates that each region itself might 
contain subpopulations of TCs [15, 46]. Th ese cells could establish close contacts 
with macrophages in sub-capsular space of kidney, and with smooth muscle bundles, 
blood vessels and nerve endings in ureter and urinary bladder [41]. 
Telocytes in the urinary bladder
Vannucchi et al. proposed that in the human urinary bladder there were at least three 
TCs subtypes, two of which located in the sub-urothelium and one in the submucosa 
and detrusor. Telocytes form a  thick multilayered area parallel to the urothelial 
surface, while in submucosa they were seen scattered within submucosa thickness. 
In detrusor TCs were present at its submucosal border and around the muscle 
bundles [13], which also were described by Ramussen et al. as CD34-positive and 
c-Kit-negative cells (called at that time ICLC) [15, 16, 47]. 
TCs in submucosa of the human urinary bladder are CD34/calreticulin-positive, 
but PDGFRα/αSMA/c-kit negative. Important to note, cells located immediately under 
the urothelium were PDGFRα/ calreticulin-positive and αSMA/CD34/c-Kit-negative, 
despite located deeper in the sub-urothelium — αSMA-positive. Th e last one were 
similarly to myofi broblasts and probably were “fi broblasts with myoid diff erentiation” 
as suggested Vannucchi et al. In the urinary bladder TCs were calreticulin-positive, 
independently on their location [13]. 
Several classes of K+ channels may participate in the regulation of detrusor 
excitability and contractility during bladder fi lling. Th ree families of Ca2+-activated 
K+ conductances have been characterized in detrusor smooth muscle cells (SMCs): 
large-conductance (BK), intermediate conductance (IK) and small conductance (SK) 
Ca2+-activated K+ channels [48, 49]. Lee et al. found that TCs in murine detrusor 
muscle express small-conductance Ca2+-activated K+ channels, most prominently the 
SK3 isoform, whereas expression of SK channels was low in smooth muscle cells [48, 
50]. As followed from this data, SK channel regulation of bladder excitability is likely 
mediated through TCs rather than through SMCs.
Platelet-derived growth factor receptor-α+ (PDGFRα) cells were also found between 
individual smooth muscle cells in smaller bundles of smooth muscle. A dense population 
of PDGFR-α+ cell was also found within the lamina propria of the bladder  with the 
cellular network closely packed in the sub-urothelium region [51]. Li et al. showed that 
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injection of renal TCs can attenuate renal dysfunction and ameliorate renal histological 
damage following renal ischemia–reperfusion injury [52]. 
Putative role of telocytes in the urinary system 
Th e function of TCs in kidney might be involved in the reparation of injured tissues 
and immune responses during disease such as acute kidney injury, renal failure and 
renal fi brosis [40]. Important to note, that telocytes are involved in pyeloureteric 
peristalsis [52]. Lang et al. described telocytes in UPJ and atypical smooth muscle 
cells as two populations of pacemaker cells [53]. Koleda et al. mentioned that telocytes 
express vanilloid receptor-like 1 protein (VRL-1/TRPV2) suggests the role they may 
have in the modulation of pyeloureteric peristalsis as sensors of physical and chemical 
stimuli [54]. His command also experimentally proved that density of UPJ telocytes 
was diff erent among normal ureters and obstructed. Increased expression of c-kit-
positive telocytes in congenital UPJ obstruction may indicate the development of 
a  compensatory mechanism for the failure of urine to be propelled from the renal 
pelvis through the ureter [54]. Zheng et al. suggested that TCs in urinary bladder 
might be involved in the reparation of injured tissue during diseases, like in the 
skeletal muscles [40]. 
Unfortunately, the quantity of data at hand is insuffi  cient for clear understanding 
the functions of telocytes in the urinary system. As they have a  close cooperation 
with muscle cells and nerve endings, possess SK channels and receptors of growth 
factors and hormones, have subtypes in the urinary bladder and detected in detrusor, 
Vannucchi et al. suggested that these cells might be involved in bladder refl exes [13]. 
One of the main functional hypotheses for bladder the upper lamina propria telocytes 
(UPL) is a  role in signal transduction between the urothelium and the underlying 
nerve endings during bladder fi lling and bladder emptying [46]. As Gevaert et al. 
concluded, a signal transduction role might then also be suggested for the ULP telocyte 
networks in the entire urinary tract, that is, during collection of urine in the renal 
pelvis, during propulsion of urine in the ureter and during the barrier function of the 
urethra. Th ese regional diff erences in function might then be refl ected by the diff erent 
(immunohistochemical) phenotypes between ULP telocytes [46]. Involvement of 
telocytes in the regulation of detrusor excitability and pathogenesis of overactive 
urinary bladder is required more detailed investigations and signifi cant data.
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